84 related articles for article (PubMed ID: 30817352)
1. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
[TBL] [Abstract][Full Text] [Related]
2. The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER database.
Hu H; Xu Y; Zhang Q; Gao Y; Wu Z
Expert Rev Anticancer Ther; 2024 Jun; 24(6):467-476. PubMed ID: 38656796
[TBL] [Abstract][Full Text] [Related]
3. Whether early stage pancreatic ductal adenocarcinoma patients could benefit from the post-operation chemotherapy regimens: a SEER-based propensity score matching study.
Shi J; Li X; Wu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 50(3):375-382. PubMed ID: 34402250
[TBL] [Abstract][Full Text] [Related]
4. The role of radiotherapy in multimodal treatment of pancreatic carcinoma.
Brunner TB; Scott-Brown M
Radiat Oncol; 2010 Jul; 5():64. PubMed ID: 20615227
[TBL] [Abstract][Full Text] [Related]
5. Impact of adjuvant external beam radiotherapy on survival in surgically resected gallbladder adenocarcinoma: a propensity score-matched Surveillance, Epidemiology, and End Results analysis.
Hyder O; Dodson RM; Sachs T; Weiss M; Mayo SC; Choti MA; Wolfgang CL; Herman JM; Pawlik TM
Surgery; 2014 Jan; 155(1):85-93. PubMed ID: 23876364
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemotherapy With or Without Radiotherapy for Resected Pancreatic Cancer After Multiagent Neoadjuvant Chemotherapy.
Franklin O; Sugawara T; Ross RB; Rodriguez Franco S; Colborn K; Karam S; Schulick RD; Del Chiaro M
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38789615
[TBL] [Abstract][Full Text] [Related]
7. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma.
López JC; Ielpo B; Iglesias M; Pinilla FB; Sánchez-Velázquez P
Langenbecks Arch Surg; 2024 Apr; 409(1):122. PubMed ID: 38607450
[TBL] [Abstract][Full Text] [Related]
8. Distal Pancreatectomy for Body Pancreatic Ductal Adenocarcinoma: Is Splenectomy Necessary? A Propensity Score Matched Study.
Codjia T; Hobeika C; Platevoet P; Pravisani R; Dokmak S; Aussilhou B; Marique L; Cros J; Cauchy F; Lesurtel M; Sauvanet A
Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38526834
[TBL] [Abstract][Full Text] [Related]
9. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8
Lee M; Thomas AS; Lee SY; Cho YJ; Jung HS; Yun WG; Han Y; Jang JY; Kluger MD; Kwon W
J Gastrointest Surg; 2023 Nov; 27(11):2484-2492. PubMed ID: 37848688
[TBL] [Abstract][Full Text] [Related]
10. Perineural Invasion is an Important Prognostic Factor in Patients With Radically Resected (R0) and Node-negative (pN0) Pancreatic Cancer.
Schouten TJ; Kroon VJ; Besselink MG; Bosscha K; Busch OR; Crobach ASLP; van Dam RM; Doukas M; Fariña Sarasquesta A; Festen S; Groot Koerkamp B; van der Harst E; Heij LR; de Hingh IHJT; Kazemier G; Liem MSL; de Meijer VE; Mieog JSD; Patijn GA; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; Wilmink HJ; Wit F; Brosens LAA; van Santvoort HC; Molenaar IQ; Daamen LA;
Ann Surg; 2024 May; ():. PubMed ID: 38708885
[TBL] [Abstract][Full Text] [Related]
11. Executive Summary of the American Radium Society Appropriate Use Criteria for Neoadjuvant Therapy for Nonmetastatic Pancreatic Adenocarcinoma: Systematic Review and Guidelines.
Jethwa KR; Kim E; Berlin J; Anker CJ; Tchelebi L; Abood G; Hallemeier CL; Jabbour S; Kennedy T; Kumar R; Lee P; Sharma N; Small W; Williams V; Russo S
Am J Clin Oncol; 2024 Apr; 47(4):185-199. PubMed ID: 38131628
[TBL] [Abstract][Full Text] [Related]
12. The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma.
Prabhu RS; Corso CD; Ward MC; Heinzerling JH; Dhakal R; Buchwald ZS; Patel KR; Asher AL; Sumrall AL; Burri SH
Neurooncol Pract; 2020 Jul; 7(4):391-399. PubMed ID: 32765890
[TBL] [Abstract][Full Text] [Related]
13. Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma.
Ang A; Michaelides A; Chelala C; Ullah D; Kocher HM;
Ann Hepatobiliary Pancreat Surg; 2024 May; 28(2):248-261. PubMed ID: 38556877
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis.
Pretzsch E; D'Haese JG; Renz B; Ilmer M; Schiergens T; Miksch RC; Albertsmeier M; Guba M; Angele MK; Werner J; Nieß H
BMC Surg; 2021 Feb; 21(1):98. PubMed ID: 33618686
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer Database.
Greco SH; August DA; Shah MM; Chen C; Moore DF; Masanam M; Turner AL; Jabbour SK; Javidian P; Grandhi MS; Kennedy TJ; Alexander HR; Carpizo DR; Langan RC
Surg Open Sci; 2021 Jan; 3():22-28. PubMed ID: 33490937
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Radiotherapy in Moderately Advanced (T3) Oral Cavity Cancers.
Wang RS; Chow MS; Gordon AJ; Santacatterina M; Vaezi AE; Tam MM; Givi B
Laryngoscope; 2024 May; 134(5):2236-2242. PubMed ID: 37937735
[TBL] [Abstract][Full Text] [Related]
17. Reappraising the Role of Intraoperative Neck Margin Revision in Post-Neoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis.
Malleo G; Lionetto G; Crippa S; Qadan M; Moser G; Belfiori G; Scarpa A; Schiavo-Lena M; Casciani F; Mattiolo P; Paiella S; Esposito A; Luchini C; Ferrone CR; Lillemoe KD; Fernández-Del Castillo C; Falconi M; Salvia R
Ann Surg; 2024 May; ():. PubMed ID: 38708617
[TBL] [Abstract][Full Text] [Related]
18. The Use of Radiation Therapy in Well-Differentiated Soft Tissue Sarcoma of the Extremities: An NCDB Review.
Lazarides AL; Eward WC; Speicher PJ; Hou CH; Nussbaum DP; Green C; Blazer DG; Kirsch DG; Brigman BE
Sarcoma; 2015; 2015():186581. PubMed ID: 26064077
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgery.
Park EJ; Jang JK; Byun JH; Kim JH; Lee SS; Kim HJ; Yoo C; Kim KP; Hong SM; Seo DW; Hwang DW; Kim SC
Abdom Radiol (NY); 2024 May; ():. PubMed ID: 38802630
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer--low survival rates.
Beger HG; Rau B; Gansauge F; Leder G; Schwarz M; Poch B
Dtsch Arztebl Int; 2008 Apr; 105(14):255-62. PubMed ID: 19629206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
